Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: An economic evaluation

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Turunen, Heidi ^a   Jakob, Stephan M ^b   Ruokonen, Esko ^c   Kaukonen, Kirsi Maija ^d,e   Sarapohja, Toni ^a   Apajasalo, Marjo ^a   Takala, Jukka ^b  

^a ORION CORPORATION   (Finland)

^b UNIVERSITY OF BERN   (Switzerland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d MONASH UNIVERSITY   (Australia)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; MIDAZOLAM; PROPOFOL; HYPNOTIC SEDATIVE AGENT;

ARTICLE; COST CONTROL; COST MINIMIZATION ANALYSIS; DRUG COST; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE; INTUBATION; LENGTH OF STAY; NONINVASIVE VENTILATION; PATIENT CARE; PRIORITY JOURNAL; SCORING SYSTEM; SEDATION; SENSITIVITY ANALYSIS; THERAPEUTIC INTERVENTION SCORING SYSTEM; ARTIFICIAL VENTILATION; CONSCIOUS SEDATION; ECONOMICS; HOSPITALIZATION; INTENSIVE CARE UNIT; META ANALYSIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CONSCIOUS SEDATION; DEXMEDETOMIDINE; HOSPITALIZATION; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; MIDAZOLAM; PROPOFOL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL;

EID: 84926660426     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-0787-y     Document Type: Article

References (40)

1. Wild C, Narath M. Evaluating and planning ICUs: methods and approaches to differentiate between need and demand. Health Policy. 2005;71:289-301. doi:10.1016/j.healthpol.2003.12.020.
2. Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: The contribution of mechanical ventilation. Crit Care Med. 2005;33:1266-71. doi:10.1097/01.CCM.0000164543. 14619.00.
3. Moerer O, Plock E, Mgbor U, Schmid A, Schneider H, Wischnewsky MB, et al. A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units. Crit Care. 2007;11:R69. doi:
4. Al MJ, Hakkaart L, Tan SS, Bakker J. Cost-consequence analysis of remifentanil-based analgo-sedation versus conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands. Crit Care. 2010;14:R195. doi:10.1186/cc9313.
5. Tan SS, Bakker J, Hoogendoorn ME, Kapila A, Martin J, Pezzi A, et al. Direct cost analysis of intensive care stay in four European countries: Applying a standardized costing methodology. Value Health. 2012;15:81-6. doi:10.1016/j.jval.2011. 09.007.
6. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, et al. Dexmedetomidine vs. midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009;301:489-99. doi:10.1001/jama.2009.56.
7. Ruokonen E, Parviainen I, Jakob SM, Nunes S, Kaukonen M, Shepherd ST, et al. Dexmedetomidine versus propofol/ midazolam for long-term sedation during mechanical ventilation. Intensive Care Med. 2008;35:282-90. doi:10.1007/s00134-008-1296-0.
8. Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: Two randomized controlled trials. JAMA. 2012;307:1151-60. doi:10.1001/jama.2012.304.
9. Kahn JM, Rubenfeld GD, Rohrbach J, Fuchs BD. Cost savings attributable to reductions in intensive care unit length of stay for mechanically ventilated patients. Med Care. 2008;46:1226-33.
10. Cooke CR. Economics of mechanical ventilation and respiratory failure. Crit Care Clin. 2012;28:39-55. doi:10.1016/j.ccc.2011.10.004.
11. Taheri P, Butz D, Greenfield L. Length of stay has minimal impact in the cost of hospital admission. J Am Coll Surg. 2000;191:123-30.
12. Drummond MF, O'Brien B, Stoddart GL, Torrance. Basic types of economic evaluation: Do all economic evaluations use the same techniques? In: Methods for the Economic Evaluation of Health Care Programmes. 2nd edition. New York: Oxford University Press, Inc. Chapter. 1997;2:11-2.
13. Cullen DJ, Civetta GM, Briggs BA, Ferrara LC. Therapeutic Intervention Scoring System: a method for quantitative comparison of patient care. Crit Care Med. 1974;2:57-60.
14. Reis Miranda D, de Rijk A, Schaufeli W. Simplified Therapeutic Intervention Scoring System: the TISS-28 items-results from a multicenter study. Crit Care Med. 1996;24:64-73.
15. Keene AR, Cullen DJ. Therapeutic Intervention Scoring System: update 1983. Crit Care Med. 1983;11:1-3.
16. Hunink MGM, Bult JR, de Vries J, Weinstein MC. Uncertainty in decision models analyzing cost-effectiveness: The joint distribution of incremental costs and effectiveness evaluated with nonparametric bootstrap method. Med Decis Making. 1998;18:337-46. doi:10.1177/0272989X9801800312.
17. Ridley S, Biggam M, Stone P. Cost of intensive therapy, A description of methodology and initial results. Anaesthesia. 1991;46:523-30.
18. Edbrooke DL, Stevens VG, Hibbert CL, Mann AJ, Wilson AJ. A new method of accurately identifying costs of individual patients in intensive care: the initial results. Intensive Care Med. 1997;23:645-50.
19. Adrie C, Alberti C, Chaix-Couturier C, Azoulay E, De Lassence A, Cohen Y, et al. Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost. J Crit Care. 2005;20:46-58. doi:10.1016/j.jcrc.2004.10.005.
20. Blomström P, Ekman M, Lundqvist CB, Calvert MJ, Freemantle N, Lönnerholm S, et al. Cost effectiveness of cardiac resynchronization therapy in the Nordic region: An analysis based on the CARE-HF trial. Eur J Heart Fail. 2008;10:869-77. doi:10.1016/j.ejheart.2008.06.018.
21. Tacconelli E, Smith G, Hieke K, Lafuma A, Bastide P. Epidemiology, medical outcomes and costs of catheter-related bloodstream infections in intensive care units of four European countries: literature- and registry-based estimates. J Hosp Infect. 2009;72:97-103. doi:10.1016/j.jhin.2008.12.012.
22. Flaatten H, Kvåle R. Cost of intensive care in a Norwegian University hospital 1997-1999. Crit Care. 2003;7:72-8. doi:10.1186/cc1865.
23. NHS Reference Costs, 2009-2010. Appendix NSRC1-NHS Trust reference cost schedules. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_123459. Accessed 11 June 2011.
24. Ringborg A, Nieuwlaat R, Lindgren P, Jönsson B, Fidan D, Maggioni AP, et al. Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace. 2008;10:403-11. doi:10.1093/europace/eun048.
25. Tan SS, Hakkaart-van Roijen L, Al MJ, Bouwmans CA, Hoogendoorn ME, Spronk PE, et al. A Microcosting Study of Intensive Care Unit Stay in the Netherlands. J Intens Care Med. 2008;23:250-7. doi:10.1177/0885066608318661.
26. Barkun JS. Length of stay has minimal impact on the cost of hospital admission. J Am Coll Surg. 2000;191:192.
27. Pasin L, Greco T, Feltracco P, Vittorio A, Neto CN, Cabrini L, et al. Dexmedetomidine as a sedative agent in critically ill patients: a meta-analysis of randomized controlled trials. PLoS One. 2013;8:e82913. doi:10.1371/journal.pone.0082913. eCollection 2013.
28. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, et al. Effect of sedation with dexmedetomidine vs. lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298:2644-53. doi:10.1001/jama.298.22.2644.
29. Maldonado J, Wysong A, van der Starre P, Block T, Miller C, Reitz BA. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 2009;50:206-17. doi:10.1176/appi.psy.50.3.206.
30. Dasta JF, Kane-Gill SL, Pencina M, Shehabi Y, Bokesch PM, Wisemandle W, et al. A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit. Crit Care Med. 2010;38:497-503. doi:10.1097/CCM.0b013e3181bc81c9.
31. Lachaine J, Beauchemin C. Economic evaluation of dexmedetomidine relative to midazolam for sedation in the intensive care unit. Can J Hosp Pharm. 2012;65:103-10.
32. Thoma BN, Li J, McDaniel CM, McDaniel CM, Wordell CJ, Cavarocchi N, et al. Clinical and Economic Impact of Substituting Dexmedetomidine for Propofol due to a US Drug Shortage: Examination of Coronary Artery Bypass Graft Patients at an Urban medical Centre. Pharmacoeconomics. 2014;32:149-57. doi:10.1007/s40273-013-0116-8.
33. Kress JP, Pohlman A, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342:1471-7. doi:10.1056/NEJM200005183422002.
34. Girard TD, Kress JP, Fuchs BD, Thomason JW, Schweickert WD, Pun BT, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371:126-34. doi:10.1016/S0140-6736(08)60105-1.
35. Martin J, Heymann A, Bäsell K, Baron R, Biniek R, Bürkle H, et al. Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care-short version. Ger Med Sci. 2010;8:Doc02. doi:10.3205/000091.
36. Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, et al. American College of Critical Care Medicine Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit. Crit Care Med. 2013;41:263-306. doi:10.1097/CCM.0b013e3182783b72.
37. Egerod I, Christensen BV, Johansen L. Trends in sedation practices in Danish intensive care units in 2003: a national survey. Intensive Care Med. 2006;32:60-6. doi:10.1007/s00134-005-2856-1.
38. Martin J, Franck M, Sigel S, Weiss M, Spies C. Changes in sedation management in German intensive care units between 2002 and 2006: a national follow-up survey. Crit Care. 2007;11:R124. doi:10.1186/cc6189.
39. Payen JF, Chanques G, Mantz J, Hercule C, Auriant I, Leguillou JL, et al. Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology. 2007;106:687-95. doi:10.1097/01.anes.0000264747.09017.da.
40. Reschreiter H, Maiden M, Kapila A. Sedation practice in the intensive care unit: a UK national survey. Crit Care. 2008;12:R152. doi:10.1186/cc7141.